Article

TP53 Mutation in Circulating exoDNA Correlates with Outcomes of Patients with Hepatocellular Carcinoma.

2020-10-05

Abstract excerpt

<h4>Background: </h4> Detection of tumor-specific mutations in exosomal DNA (exoDNA), a promising liquid biopsy material, has been used to assess the prognosis of hepatocellular carcinoma (HCC) patients. This study was the first to use a droplet digital PCR (ddPCR) platform to detect tumor-specific mutations in circulating exoDNA and to evaluate the prognosis of HCC patients. <h4>Methods: </h4> Blood samples from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: de9e3935-1173-5e90-b50e-2e560810a919
DOI: 10.21203/rs.3.rs-72200/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

TP53 Mutation in Circulating exoDNA Correlates with Outcomes of Patients with Hepatocellular Carcinoma.DOI 10.21203/rs.3.rs-72200/v1Read

TP53 Mutation in Circulating exoDNA Correlates With Outcomes of Patients With Hepatocellular CarcinomaSemantic proximity Read

TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma.Semantic proximity Read

Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral HeterogeneitySemantic proximity Read

TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.Semantic proximity Read

A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.Semantic proximity Read

Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review.Semantic proximity Read

Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.Semantic proximity Read

Plasma Circulating Tumor DNA Sequencing Reveals the Landscape of Acquired Mutations in Patients with Hepatocellular Carcinoma: a Potential Predictive Value in Liquid BiopsySemantic proximity Read

Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized MedicineSemantic proximity Read

Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma.Semantic proximity Read

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinomaSemantic proximity Read

Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinomaSemantic proximity Read